Cancer and Female Sexual Function.

Autor: Falk SJ; Sexual Health Program, Adult Survivorship Program, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: sandy_falk@dfci.harvard.edu., Bober S; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, SW320, Boston, MA 02215, USA.

Publikováno v: Obstetrics and gynecology clinics of North America [Obstet Gynecol Clin North Am] 2024 Jun; Vol. 51 (2), pp. 365-380. Date of Electronic Publication: 2024 Apr 10.

Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations.

Autor: Baumrin E; Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: Emily.Baumrin@pennmedicine.upenn.edu., Loren AW; Blood and Marrow Transplant, Cell Therapy and Transplant Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Falk SJ; Adult Survivorship Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Mays JW; Oral Immunobiology Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland., Cowen EW; Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Jan; Vol. 90 (1), pp. 1-16. Date of Electronic Publication: 2022 Dec 23.

FBXO47 regulates centromere pairing as key component of centromeric SCF E3 ligase in mouse spermatocytes.

Autor: Ma, Ani^1,2 (AUTHOR) maani0431@126.com, Yang, Yali¹ (AUTHOR), Cao, Lianbao³ (AUTHOR), Chen, Lijun² (AUTHOR), Zhang, Jian V.^1,4,5 (AUTHOR) jian.zhang@siat.ac.cn

Publikováno v: Communications Biology. 9/7/2024, Vol. 7 Issue 1, p1-14. 14p.

An open-label study of belumosudil, a selective ROCK2 inhibitor, as second or subsequent line of therapy for steroid-dependent/steroid-resistant chronic GVHD.

Autor: Inamoto Y; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.; Department of Blood and Marrow Transplantation and Cellular Therapy, Fujita Health University, Toyoake, Japan., Kato K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan., Kawakita T; Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan., Onishi Y; Department of Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan., Matsuoka KI; Department of Hematology and Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan., Shiratori S; Department of Hematology, Hokkaido University Faculty of Medicine, Hokkaido, Japan., Ikegame K; Department of Hematology, Hyogo Medical University Hospital, Hyogo, Japan., Hiramoto N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan., Toyosaki M; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan., Katayama Y; Department of Hematology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan., Murayama S; Meiji Seika Pharma Co., Ltd., Tokyo, Japan., Sasagawa Y; Meiji Seika Pharma Co., Ltd., Tokyo, Japan., Maeda Y; Department of Hematology and Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan., Hatake K; Department of Hematology, Akasaka Sanno Medical Center, Tokyo, Japan.; School of Medicine, International University of Health and Welfare, Tokyo, Japan., Teshima T; Department of Hematology, Hokkaido University Faculty of Medicine, Hokkaido, Japan.

Publikováno v: American journal of hematology [Am J Hematol] 2024 Oct; Vol. 99 (10), pp. 1917-1926. Date of Electronic Publication: 2024 Jun 27.

Sexual health—a topic for cancer patients receiving oncological treatment with palliative intent.

Autor: Schmalz, Claudia¹ claudia.schmalz@uksh.de, Oberguggenberger, Anne S.², Nagele, Eva³, Bliem, Brigitte³, Lanceley, Anne⁴, Nordin, Andy⁵, Kuljanic, Karin⁶, Jensen, Pernille T.⁷, Bjelic-Radisic, Vesna⁸, Fabian, Alexander¹, Arraras, Juan I.⁹, Wei-Chu, Chie¹⁰, Creutzberg, Carien L.¹¹, Galalae, Razvan¹², Toelen, Hilde¹³, Zimmermann, Kristin¹⁴, Costantini, Anna¹⁵, Almont, Thierry¹⁶, Serpentini, Samantha¹⁷, Frøding, Ligita Paskeviciute¹⁸

Publikováno v: BMC Palliative Care. 7/29/2024, Vol. 23 Issue 1, p1-7. 7p.